Research map: PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression

Back to the article

Papers in this map

  1. Pathogen Recognition and Innate Immunity · Shizuo Akira · 2006 · 12075 citations · Cited by this paper
  2. Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation · Meng‐Ling Wu · 2022 · 473 citations · Cites this paper
  3. HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · 2026 · Related
  4. PD-1 blockade induces responses by inhibiting adaptive immune resistance · Paul C. Tumeh · 2014 · 6779 citations · Cited by this paper
  5. Neutrophil diversity and function in health and disease · F Zhang · 2024 · 245 citations · Cites this paper
  6. Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · 2026 · Related
  7. Nivolumab in Previously Untreated Melanoma without BRAF Mutation · Caroline Robert · 2014 · 5444 citations · Cited by this paper
  8. Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration · Kaiting Yang · 2022 · 222 citations · Cites this paper
  9. Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · 2026 · Related
  10. Toll-Like Receptor Signaling Pathways · Takumi Kawasaki · 2014 · 3308 citations · Cited by this paper
  11. Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments · Lisa A. Feldman · 2024 · 77 citations · Cites this paper
  12. Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · 2026 · Related
  13. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer · Teresa A. Soucy · 2009 · 2048 citations · Cited by this paper
  14. Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential · Wen-Qin Zhang · 2022 · 54 citations · Cites this paper
  15. Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · 2026 · Related
  16. Trained Immunity: A Memory for Innate Host Defense · Mihai Gheorghe Netea · 2011 · 1712 citations · Cited by this paper
  17. CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer · Yanna Li · 2024 · 53 citations · Cites this paper
  18. Programmed cell death protein 1 (PD-1) / programmed cell death ligand 1 (PD-L1) in multiple myeloma · 2026 · Related
  19. Neddylation inhibition upregulates PD‐L1 expression and enhances the efficacy of immune checkpoint blockade in glioblastoma · Shaolong Zhou · 2019 · 64 citations · Cited by this paper
  20. Porphyrin-based metal—organic framework nanocrystals for combination of immune and sonodynamic therapy · Sen Jiang · 2023 · 37 citations · Cites this paper
  21. Unmasking a Paradox: Roles of the PD-1/PD-L1 Axis in Alzheimer's Disease-Associated Neuroinflammation · 2025 · Related
  22. Untitled · Cited by this paper
  23. Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis · Claudia Tanja Mierke · 2024 · 32 citations · Cites this paper
  24. Unravelling inflammation-driven mechanisms in hepatocellular carcinoma: therapeutic targets and potential interventions · 2025 · Related
  25. Untitled · Cited by this paper
  26. Deep learning for multi-grade brain tumor detection and classification: a prospective survey · K. Bhagyalaxmi · 2024 · 31 citations · Cites this paper
  27. Untitled · Cited by this paper
  28. Preclinical development and clinical studies of targeted JAK/STAT combined Anti-PD-1/PD-L1 therapy · Miaomiao Chen · 2024 · 29 citations · Cites this paper
  29. Untitled · Cited by this paper
  30. Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic Agents · Jin Liu · 2023 · 28 citations · Cites this paper
  31. Untitled · Cited by this paper
  32. Astrocyte interferon-gamma signaling dampens inflammation during chronic central nervous system autoimmunity via PD-L1 · Brandon C. Smith · 2023 · 28 citations · Cites this paper
  33. Untitled · Cited by this paper
  34. Dostarlimab an Inhibitor of PD-1/PD-L1: A New Paradigm for the Treatment of Cancer · Faisal K. Alkholifi · 2022 · 27 citations · Cites this paper
  35. Untitled · Cited by this paper
  36. Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances · Gaoli Niu · 2024 · 27 citations · Cites this paper
  37. Untitled · Cited by this paper
  38. The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer · Ritu Yadav · 2024 · 25 citations · Cites this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)